Title : In search of a real "targeted" therapy for thyroid cancer.

Pub. Date : 2012 Apr 1

PMID : 22451620






1 Functional Relationships(s)
Download
Sentence
Compound Name
Protein Name
Organism
1 Here, selumetinib targets the mitogen-activated protein kinase pathway in papillary thyroid carcinoma and shows limited single-agent activity in the patients with tumors that harbor the (V600E)BRAF mutation. AZD 6244 B-Raf proto-oncogene, serine/threonine kinase Homo sapiens